These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9811074

  • 1. Effects of sputum oscillations and rhDNase in vitro: a combined approach to treat cystic fibrosis lung disease.
    Dasgupta B, Brown NE, King M.
    Pediatr Pulmonol; 1998 Oct; 26(4):250-5. PubMed ID: 9811074
    [Abstract] [Full Text] [Related]

  • 2. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M, Dasgupta B, Tomkiewicz RP, Brown NE.
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [Abstract] [Full Text] [Related]

  • 3. Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.
    Dasgupta B, King M.
    Pediatr Pulmonol; 1996 Sep; 22(3):161-6. PubMed ID: 8893254
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage.
    App EM, Kieselmann R, Reinhardt D, Lindemann H, Dasgupta B, King M, Brand P.
    Chest; 1998 Jul; 114(1):171-7. PubMed ID: 9674466
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant human DNase (rhDNase) influences phospholipid composition, surface activity, rheology and consecutively clearance indices of cystic fibrosis sputum.
    Griese M, App EM, Duroux A, Burkert A, Schams A.
    Pulm Pharmacol Ther; 1997 Jul; 10(1):21-7. PubMed ID: 9344829
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial.
    Radtke T, Böni L, Bohnacker P, Maggi-Beba M, Fischer P, Kriemler S, Benden C, Dressel H.
    BMC Pulm Med; 2018 Jun 14; 18(1):99. PubMed ID: 29898704
    [Abstract] [Full Text] [Related]

  • 11. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
    Guichard MJ, Kinoo D, Aubriot AS, Bauwens N, Gougué J, Vermeulen F, Lebecque P, Leal T, Vanbever R.
    Clin Sci (Lond); 2018 Jul 18; 132(13):1439-1452. PubMed ID: 29871879
    [Abstract] [Full Text] [Related]

  • 12. Effects of treadmill exercise versus Flutter® on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial.
    Dwyer TJ, Zainuldin R, Daviskas E, Bye PT, Alison JA.
    BMC Pulm Med; 2017 Jan 11; 17(1):14. PubMed ID: 28077104
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.
    Suri R.
    BioDrugs; 2005 Jan 11; 19(3):135-44. PubMed ID: 15984899
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
    Henry RL, Gibson PG, Carty K, Cai Y, Francis JL.
    Pediatr Pulmonol; 1998 Aug 11; 26(2):97-100. PubMed ID: 9727759
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical trials of recombinant human DNase in cystic fibrosis patients.
    Aitken ML.
    Monaldi Arch Chest Dis; 1993 Dec 11; 48(6):653-6. PubMed ID: 8124306
    [Abstract] [Full Text] [Related]

  • 20. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.